focus -WSS

focus

author：comprehensive 2025-09-29 06:52:36 - browse：867

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： What will Novo Nordisk's VC do with its influx of cash?

focus

WSS

Some top drug companies are starting to take action on climate

Medicare Advantage isn’t working — for anyone

The biotech scorecard for Q4: 16 stock

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

CDC picks Alphabet's Verily for wasterwater surveillance contract

Nobel honors Karikó and Weissman's enduring partnership

knowledge

focus

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

What we owe ALS patients — and why one company fell short

The cancer drug shortage isn’t new — and neither are the solutions

Laying a path for careers in science

In age of alternative facts, a scholarly course on calling out crap

https://cbu01.alicdn.com/img/ibank/2017/871/352/4611253178_2072393276.220x220xz.jpg

United colonoscopy coverage change 'may cost lives,' doctors say

Cholera vaccine supplies dangerously low, outbreaks surging

Wildfire smoke exposes gaps in outdoor worker protections

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

focus

Study fuels hope CAR

With Roe v Wade overturned, abortion providers work to adapt

RSV injection headlines need to be accurate for good uptake

Elisabeth Bik tackles the widespread issue of research misconduct

What we owe ALS patients — and why one company fell short

CDC advisory group OKs chikungunya vaccine

hotspot

explore

focus

explore